Barnard Katharine D, Hood Korey K, Weissberg-Benchell Jill, Aldred Chris, Oliver Nick, Laffel Lori
1 Human Development and Health Academic Unit, Faculty of Medicine, University of Southampton , Southampton, United Kingdom .
Diabetes Technol Ther. 2015 Apr;17(4):295-300. doi: 10.1089/dia.2014.0305. Epub 2014 Dec 30.
This study aimed to systematically review the evidence base for the use of existing psychological and psychosocial measures suitable for use in artificial pancreas (AP) research.
This systematic review of published literature, gray literature, previous systematic reviews, and qualitative and economic studies was conducted using terms and abbreviations synonymous with diabetes, AP, and quality of life (QoL).
Two hundred ninety-two abstracts were identified that reported psychosocial assessment of diabetes-related technologies. Of these, nine met the inclusion criteria and were included. Only four of 103 ongoing trials evaluated psychosocial aspects as an outcome in the trial. Of these, treatment satisfaction, acceptance and use intention of AP, fear of hypoglycemia episodes, satisfaction with AP, and an unspecified QoL measure were used.
A better understanding of the psychosocial side of AP systems and the extent to which human factors play a role in the uptake and efficient use of these systems will ultimately lead to the most benefit for people with diabetes.
本研究旨在系统回顾适用于人工胰腺（AP）研究的现有心理和社会心理测量方法的证据基础。
本系统综述通过使用与糖尿病、AP和生活质量（QoL）同义的术语和缩写，对已发表的文献、灰色文献、先前的系统综述以及定性和经济研究进行了检索。
共识别出292篇报告糖尿病相关技术心理社会评估的摘要。其中，9篇符合纳入标准并被纳入。在103项正在进行的试验中，只有4项将心理社会方面作为试验结果进行评估。这些试验使用了治疗满意度、AP的接受度和使用意愿、对低血糖发作的恐惧、对AP的满意度以及一项未明确的生活质量测量指标。
更好地理解AP系统的心理社会层面以及人为因素在这些系统的采用和有效使用中所起的作用程度，最终将为糖尿病患者带来最大益处。
